The importance of total number of sentinel lymph nodes in patients with stage NO cutaneous melanoma

Laura E. Stewart, Douglas Tyler, Robin T. Vollmer

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Staging of malignant melanoma now relies routinely on the sentinel node (SN) technique. On average, 2.1 SNs are removed per patient. Nevertheless, despite the success of the SN technique, approximately 10% of patients with negative SNs experience metastatic recurrence. Because a prior theoretical analysis using Poisson and Bayes probability models suggested that limited sampling of SNs could cause false-negative results, we undertook this study to see whether the subset of patients with negative SNs and only 1 or 2 nodes examined have a shorter time to recurrence than patients with 3 or more nodes examined and found to be negative. Our study cases comprised 178 melanoma cases with SN biopsy: positive SN, 47; negative SN and fewer than 3 nodes examined, 68; and negative SN and more than 2 nodes examined, 63. Patients with negative SNs and fewer than 3 examined had disease-free survival intermediate between patients with positive SNs and those with negative SNs and more than 2 examined (P = .013). These results suggest that among patients with negative SNs, those with fewer than 3 nodes examined have greater risk for recurrence.

Original languageEnglish (US)
Pages (from-to)77-82
Number of pages6
JournalAmerican Journal of Clinical Pathology
Volume124
Issue number1
DOIs
StatePublished - Jul 2005
Externally publishedYes

Fingerprint

Melanoma
Skin
Recurrence
Sentinel Lymph Node
Disease-Free Survival
cyhalothrin
Biopsy

Keywords

  • Melanoma
  • Metastasis
  • Probability
  • Sentinel node
  • Tumor recurrence

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

The importance of total number of sentinel lymph nodes in patients with stage NO cutaneous melanoma. / Stewart, Laura E.; Tyler, Douglas; Vollmer, Robin T.

In: American Journal of Clinical Pathology, Vol. 124, No. 1, 07.2005, p. 77-82.

Research output: Contribution to journalArticle

@article{a2797a0e288d488c94a6cad8dcd697a9,
title = "The importance of total number of sentinel lymph nodes in patients with stage NO cutaneous melanoma",
abstract = "Staging of malignant melanoma now relies routinely on the sentinel node (SN) technique. On average, 2.1 SNs are removed per patient. Nevertheless, despite the success of the SN technique, approximately 10{\%} of patients with negative SNs experience metastatic recurrence. Because a prior theoretical analysis using Poisson and Bayes probability models suggested that limited sampling of SNs could cause false-negative results, we undertook this study to see whether the subset of patients with negative SNs and only 1 or 2 nodes examined have a shorter time to recurrence than patients with 3 or more nodes examined and found to be negative. Our study cases comprised 178 melanoma cases with SN biopsy: positive SN, 47; negative SN and fewer than 3 nodes examined, 68; and negative SN and more than 2 nodes examined, 63. Patients with negative SNs and fewer than 3 examined had disease-free survival intermediate between patients with positive SNs and those with negative SNs and more than 2 examined (P = .013). These results suggest that among patients with negative SNs, those with fewer than 3 nodes examined have greater risk for recurrence.",
keywords = "Melanoma, Metastasis, Probability, Sentinel node, Tumor recurrence",
author = "Stewart, {Laura E.} and Douglas Tyler and Vollmer, {Robin T.}",
year = "2005",
month = "7",
doi = "10.1309/XTR5-DA5L-3N26-JR8J",
language = "English (US)",
volume = "124",
pages = "77--82",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "1",

}

TY - JOUR

T1 - The importance of total number of sentinel lymph nodes in patients with stage NO cutaneous melanoma

AU - Stewart, Laura E.

AU - Tyler, Douglas

AU - Vollmer, Robin T.

PY - 2005/7

Y1 - 2005/7

N2 - Staging of malignant melanoma now relies routinely on the sentinel node (SN) technique. On average, 2.1 SNs are removed per patient. Nevertheless, despite the success of the SN technique, approximately 10% of patients with negative SNs experience metastatic recurrence. Because a prior theoretical analysis using Poisson and Bayes probability models suggested that limited sampling of SNs could cause false-negative results, we undertook this study to see whether the subset of patients with negative SNs and only 1 or 2 nodes examined have a shorter time to recurrence than patients with 3 or more nodes examined and found to be negative. Our study cases comprised 178 melanoma cases with SN biopsy: positive SN, 47; negative SN and fewer than 3 nodes examined, 68; and negative SN and more than 2 nodes examined, 63. Patients with negative SNs and fewer than 3 examined had disease-free survival intermediate between patients with positive SNs and those with negative SNs and more than 2 examined (P = .013). These results suggest that among patients with negative SNs, those with fewer than 3 nodes examined have greater risk for recurrence.

AB - Staging of malignant melanoma now relies routinely on the sentinel node (SN) technique. On average, 2.1 SNs are removed per patient. Nevertheless, despite the success of the SN technique, approximately 10% of patients with negative SNs experience metastatic recurrence. Because a prior theoretical analysis using Poisson and Bayes probability models suggested that limited sampling of SNs could cause false-negative results, we undertook this study to see whether the subset of patients with negative SNs and only 1 or 2 nodes examined have a shorter time to recurrence than patients with 3 or more nodes examined and found to be negative. Our study cases comprised 178 melanoma cases with SN biopsy: positive SN, 47; negative SN and fewer than 3 nodes examined, 68; and negative SN and more than 2 nodes examined, 63. Patients with negative SNs and fewer than 3 examined had disease-free survival intermediate between patients with positive SNs and those with negative SNs and more than 2 examined (P = .013). These results suggest that among patients with negative SNs, those with fewer than 3 nodes examined have greater risk for recurrence.

KW - Melanoma

KW - Metastasis

KW - Probability

KW - Sentinel node

KW - Tumor recurrence

UR - http://www.scopus.com/inward/record.url?scp=21744445071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21744445071&partnerID=8YFLogxK

U2 - 10.1309/XTR5-DA5L-3N26-JR8J

DO - 10.1309/XTR5-DA5L-3N26-JR8J

M3 - Article

VL - 124

SP - 77

EP - 82

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 1

ER -